From: The impact of secondary hyperparathyroidism on the efficacy of antiresorptive therapy
Number of patients
138
Women/men
116/22
Mean age (years)
64.82 ± 10.51
Treatment
Alendronate:97
Risedronate: 19
Zolendronate: 7
Ibandronate:15